Analyst Called This Pharma Stock an "Undervalued Growth Story"

The analyst's rating joins a resoundingly bullish crowd

Digital Content Manager
May 3, 2019 at 11:32 AM
facebook twitter linkedin

H.C. Wainwright just initiated coverage on the drugmaker Collegium Pharmaceutical, Inc (NASDAQ:COLL) with a "buy" rating and a $23 price target -- a roughly 60% upside to the stock's current perch at $13.60. The analyst called the firm, which specializes in abuse-deterrent pain treatments, an "undervalued growth story," especially given the current backdrop surrounding opioid abuse. 

On the charts, COLL appears to have found a floor right atop its mid-February, 19-month low of $13.10. While the equity has bounced along this region recently, some pressure at its 20-day moving average has caused it to retreat back towards its yearly lows. At last check, the stock was down 19.7% this year.

COLL Chart May 3

Despite this negative price action, analysts are resoundingly optimistic on Collegium. The stock boasts a whopping eight "strong buy" ratings, one "buy" and not a single "hold" or "sell." Plus, the consensus 12-month target price of $28 more than doubles current levels. 

Short sellers have been leaping from their bearish bandwagon, too. COLL short interest fell by over a quarter in the last reporting period. The 2.17 million shares sold short still represent a solid 7.3% of the stock's available float, however, and over six days of trading at the equity's average daily pace. This means there's still plenty of room for a short squeeze. 




Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners